1. Home
  2. TENX vs PVL Comparison

TENX vs PVL Comparison

Compare TENX & PVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

BUY

Current Price

$1.49

Market Cap

74.1M

Sector

Health Care

ML Signal

BUY

Logo Permianville Royalty Trust Trust Units

PVL

Permianville Royalty Trust Trust Units

HOLD

Current Price

$1.80

Market Cap

60.1M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
PVL
Founded
1967
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
60.1M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
TENX
PVL
Price
$1.49
$1.80
Analyst Decision
Buy
Analyst Count
10
0
Target Price
★ $12.56
N/A
AVG Volume (30 Days)
★ 2.2M
57.4K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
★ 11.79%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$26.85
Revenue Growth
N/A
★ N/A
52 Week Low
$1.31
$1.58
52 Week High
$19.40
$2.01

Technical Indicators

Market Signals
Indicator
TENX
PVL
Relative Strength Index (RSI) 28.27 44.25
Support Level $1.31 $1.79
Resistance Level $2.00 $1.84
Average True Range (ATR) 0.11 0.04
MACD 0.07 -0.00
Stochastic Oscillator 18.77 50.00

Price Performance

Historical Comparison
TENX
PVL

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About PVL Permianville Royalty Trust Trust Units

Permianville Royalty Trust is a statutory trust which holds net profits interests in the profits from the sale of oil and natural gas production from non-operated assets of both conventional properties in the States of Texas, Louisiana, and New Mexico as well as unconventional assets in the Permian and Haynesville basins.

Share on Social Networks: